RAUL ISERN: Open Payments
NPI 1417081852 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 11 payments from 4 companies in 2025. Trend: 2023 $667 · 2024 $547 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $316 |
| ABBVIE INC. | 3 | $183 |
| Vanda Pharmaceuticals Inc. | 3 | $86 |
| Tris Pharma Inc | 1 | $18 |
Products named: CAPLYTA, VRAYLAR, HETLIOZ, FANAPT, Dyanavel XR.
Industry payments across TX — which companies pay providers there.
